CX Institutional’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.57M Buy
94,489
+14,257
+18% +$1.3M 0.25% 97
2026
Q1
$8.24M Buy
80,232
+52,723
+192% +$5.95M 0.25% 93
2025
Q4
$3.45M Sell
27,509
-1,766
-6% -$225K 0.1% 162
2025
Q3
$3.92M Buy
29,275
+4,310
+17% +$566K 0.12% 158
2025
Q2
$3.4M Sell
24,965
-39,807
-61% -$5.25M 0.12% 160
2025
Q1
$8.59M Buy
64,772
+50,529
+355% +$6.43M 0.32% 70
2024
Q4
$1.61M Buy
14,243
+1,790
+14% +$207K 0.06% 194
2024
Q3
$1.42M Sell
12,453
-428
-3% -$46.9K 0.06% 235
2024
Q2
$1.34M Buy
12,881
+397
+3% +$42.1K 0.06% 234
2024
Q1
$1.42M Buy
12,484
+1,920
+18% +$220K 0.07% 227
2023
Q4
$1.16M Sell
10,564
-11,006
-51% -$1.1M 0.06% 236
2023
Q3
$2.09M Sell
21,570
-38,551
-64% -$4.05M 0.12% 190
2023
Q2
$6.55M Buy
60,121
+2,818
+5% +$300K 0.34% 83
2023
Q1
$5.82M Buy
57,303
+8,445
+17% +$892K 0.31% 85
2022
Q4
$5.36M Buy
48,858
+16,222
+50% +$1.68M 0.33% 74
2022
Q3
$3.16M Buy
32,636
+21,894
+204% +$2.33M 0.22% 111
2022
Q2
$1.17M Sell
10,742
-849
-7% -$96.4K 0.09% 228
2022
Q1
$1.37M Buy
11,591
+781
+7% +$96.8K 0.11% 193
2021
Q4
$1.52M Buy
10,810
+64
+0.6% +$8.19K 0.12% 170
2021
Q3
$1.27M Buy
10,746
+798
+8% +$98K 0.1% 193
2021
Q2
$1.15M Buy
9,948
+31
+0.3% +$3.61K 0.09% 196
2021
Q1
$1.19M Sell
9,917
-70
-0.7% -$8.29K 0.11% 186
2020
Q4
$1.09M Buy
9,987
+13
+0.1% +$1.41K 0.11% 188
2020
Q3
$1.08M Buy
9,974
+1,135
+13% +$115K 0.12% 167
2020
Q2
$808K Sell
8,839
-3,776
-30% -$341K 0.11% 159
2020
Q1
$995K Buy
12,615
+3,967
+46% +$331K 0.16% 136
2019
Q4
$751K Hold
8,648
0.13% 127
2019
Q3
$724K Sell
8,648
-129
-1% -$11K 0.12% 146
2019
Q2
$738K Buy
8,777
+136
+2% +$10.7K 0.12% 143
2019
Q1
$691K Buy
8,641
+540
+7% +$40.2K 0.12% 148
2018
Q4
$586K Buy
8,101
+7,385
+1,031% +$519K 0.12% 126
2018
Q3
$53K Hold
716
0.02% 181
2018
Q2
$44K Buy
+716
New +$43.4K 0.02% 165

Other funds holding ABT

CX Institutional's ABT Position: Q2 2026 in Review

CX Institutional increased its Abbott (ABT) stake by 18% in Q2 2026, buying an estimated $1.3M and bringing the position to 94,489 shares worth $8.57M. The position accounts for 0.25% of the portfolio, ranked #97.

CX Institutional first reported a position in ABT in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.59M in Q1 2025. 673 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • CX Institutional held 94,489 shares of Abbott worth $8.57M as of Q2 2026.
  • CX Institutional bought 14,257 Abbott shares in Q2 2026, an estimated $1.3M.
  • Abbott made up 0.25% of CX Institutional's portfolio in Q2 2026, its #97 holding.
  • CX Institutional first reported a position in Abbott in Q2 2018 and has held it in 33 quarters since.
  • CX Institutional's Abbott position peaked at $8.59M in Q1 2025.
  • 673 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.